All lobbying filings

INNOVATIVE FEDERAL STRATEGIES, LLC

INNOVATIVE FEDERAL STRATEGIES, LLC filed a Q3 report for ACURX PHARMACEUTICALS, INC. on October 20, 2026, reporting $30,000 in lobbying income.

Lobbying for ACURX PHARMACEUTICALS, INC. · biopharmaceutical company

All filings by INNOVATIVE FEDERAL STRATEGIES, LLC · Everything ACURX PHARMACEUTICALS, INC. has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 20, 2026

Income

$30,000

What the client paid this registrant for the period.

Client based in

New York

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Budget/Appropriations

H.R.9260/S.____, Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations bill, 2027, Title II, all provisions related research and clinical trials for the development of antibiotics for infections caused by bacteria listed as priority pathogens.

Bills named in this filing 1

H.R. 9260
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.